Clinical Trials Logo

Clinical Trial Summary

Tapia syndrome is a rare and poorly understood pathology. It is defined by a concomitant attack of the recurrent (branch of X) and hypoglossal (XII) nerves of peripheral or central origin. It is characterized by the paralysis of a vocal cord and the ipsilateral half of tongue. This damage is most often unilateral but it can also be bilateral. It results in dysphonia and swallowing disorders. Tapia syndrome is a rare and poorly understood pathology. To date, less than 100 cases have been described in the literature. Previous works are mainly case reports and literature reviews. No prevalence study has been performed to date. Furthermore, disagreements persist regarding the semiology. Indeed, the involvement of the soft palate is not always described.


Clinical Trial Description

The main aim of this study was to determine the prevalence of Tapia syndrome in patients admitted to weaning unit after prolonged (>48h) orotracheal intubation in the ICU. The secondary objectives are to: - Describe the clinical semiology of Tapia syndrome : lingual involvement, soft palate involvement, impairment of phonation and swallowing ; - Describe the paraclinical features of Tapia syndrome: recurrent involvement, laryngeal and lingual involvement; - Identify factors associated with Tapia's syndrome ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06033144
Study type Observational
Source Hopital Forcilles
Contact
Status Enrolling by invitation
Phase
Start date April 7, 2023
Completion date April 7, 2025